1. Home
  2. HTCR vs NVNO Comparison

HTCR vs NVNO Comparison

Compare HTCR & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • NVNO
  • Stock Information
  • Founded
  • HTCR 2009
  • NVNO 1987
  • Country
  • HTCR Japan
  • NVNO United States
  • Employees
  • HTCR N/A
  • NVNO N/A
  • Industry
  • HTCR EDP Services
  • NVNO Medical/Dental Instruments
  • Sector
  • HTCR Technology
  • NVNO Health Care
  • Exchange
  • HTCR Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • HTCR 16.9M
  • NVNO 16.7M
  • IPO Year
  • HTCR 2022
  • NVNO N/A
  • Fundamental
  • Price
  • HTCR $0.96
  • NVNO $0.78
  • Analyst Decision
  • HTCR
  • NVNO
  • Analyst Count
  • HTCR 0
  • NVNO 0
  • Target Price
  • HTCR N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • HTCR 2.4M
  • NVNO 2.3M
  • Earning Date
  • HTCR 08-13-2025
  • NVNO 10-30-2025
  • Dividend Yield
  • HTCR N/A
  • NVNO N/A
  • EPS Growth
  • HTCR N/A
  • NVNO N/A
  • EPS
  • HTCR N/A
  • NVNO N/A
  • Revenue
  • HTCR $29,625,381.00
  • NVNO N/A
  • Revenue This Year
  • HTCR N/A
  • NVNO N/A
  • Revenue Next Year
  • HTCR $3.52
  • NVNO N/A
  • P/E Ratio
  • HTCR N/A
  • NVNO N/A
  • Revenue Growth
  • HTCR 72.95
  • NVNO N/A
  • 52 Week Low
  • HTCR $0.39
  • NVNO $0.67
  • 52 Week High
  • HTCR $3.38
  • NVNO $5.70
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 55.00
  • NVNO 20.18
  • Support Level
  • HTCR $0.84
  • NVNO $0.67
  • Resistance Level
  • HTCR $1.15
  • NVNO $1.12
  • Average True Range (ATR)
  • HTCR 0.23
  • NVNO 0.07
  • MACD
  • HTCR -0.02
  • NVNO 0.06
  • Stochastic Oscillator
  • HTCR 24.20
  • NVNO 30.75

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: